Through control of particle size and shape, and smooth, low-energy surfaces, mSAS® particles demonstrate impressive aerodynamic performance. This enables high levels of lung deposition from simple, off-the-shelf devices, reducing both drug and device development timelines. This video is a visual comparison of the aerosolisation ability of mSAS® vs micronised particles.